The characterization of substances which inhibit the multipfication of pneumonia virus of mice and mumps virus (1) and the identification of those cellular constituents with which certain bacterial viruses combine immediately prior to infection of the host and subsequent viral mnltipfication (2) have been subjects of investigation in these laboratories during the past several years. In undertaking the latter problem the T series of bacteriophages and the host cells E. coli 13 (3) and Sh. sonnei Phase I and II (4) were selected for study, first, because the viruses themselves have been so well characterized, and, second, because the antigenic structures of the two Sonne bacilli have been extensively investigated (5).
tube in the series contained 0.5 cc. of inhibitor (2 nag. per cc.) which had been dissolved in 0.1 M phosphate buffer at pH 7.2; all subsequent dilutions (in increments of 10) were made in nutrient broth. A fifth tube served as a control, and contained 0.5 cc. of broth. 0.5 cc. of the virus dilution was added to each of the five tubes and the latter were incubated at 37°C. for 24 hours. 0.1 cc. of each inhibitor-virus mixture was plated, and plaque countsweremade after 12 hours of incubation. In several instances a second control was included in the experiment in which virus was diluted not with broth, but with 0.1 M phosphate buffer (comparable to the first inhibition tube). The diluent made no difference, however, in the final plaque count. This test will also be referred to later as a test for the "resistance pattern" of a given virus.
EXPF~ rMENTAL
Agglutination Reactions of E. coli B and Phase I and II Sh. sonnei in Homologous and in 'Heterologous Antisera:--In order to study the serological rela- tionship between E. coli B and Phase I and II Sh. sonnei, agglutination reactions of the three microorganisms in E. coli B antiserum were first carried out. These tests are recorded in Table I . It can be seen that Phase II Sh. sonnei is agglutinated by E. coli B antiserum in high dilution, although the Phase I organism is not. This fact indicates that the Phase II bacillus possesses an antigen related to that on the surface of the colon bacillus. Further evidence in support of this is presented in Table II where it is seen that E. coli B agglutinates in the sera of rabbits immunized with Phase II bacilli, as well as in an antiserum prepared by injecting animals with the purified and electrophoretically homogeneous somatic antigen obtained from the Phase II dysentery organism. The latter serum presumably contains antibodies directed against only the specific antigen of the Phase II bacillus and not toward other surface components of the microorganism. In view of the fact that E. coli B is aggluscure but the observation is being actively followed up. A single highly active preparation was used throughout the work reported here. Preparations of the Phase II somatic antigen, when kept in the dry state for periods as long as 15 months, have shown no diminution in their ability to inhibit susceptible phages.
tinated by this antiserum, it seems reasonable to conclude that the colon bacillus possesses a surface antigen closely related to that present in Phase II Sh. sonnei.
Still further evidence is derived from the fact that solutions of the Phase II somatic antigen precipitate in E. coli B antiserum (Table III) . To be sure, the reaction is not as vigorous as that in homologous antiserum, yet precipitation occurs with reasonably high dilutions of the Phase II antigen. It is unfor- It is apparent from Table IV that absorption of the immune serum with E. coli B removes only agglutinins for the latter microorganism and leaves those still specifically reactive with the Phase II hacmus. Absorption of the serum with the heterologous microorganism has apparently diminished but slightly its agglutinative power for the homologous Phase II bacillus. Quantitative nephelometric precipitin measurements of the serum antibody reveal, however (Pig. 1) that some 30 per cent of the total antibody present in the original serum, To varying quantifies of a dilution (0.2 cc. of serum per ce.) of the original and absorbed sera, and at constant volume (1 cc.), was added 1 ec. of a solution containing 50 micrograms of Phase II antigen. The turbidity which developed was measured, and the results plotted as indicated in the accompanying figure. The results of these experiments further substantiate the evidence already presented that the somatic antigen of Phase II Sit. s~nei is related to, but not identical with, that found on the cell surface of E. coli B. In this respect the two antigens are analogous to the capsular polysaecharides of Types III and VIII pneumococcus (11) . whether lysis of the colon bacillus by the T phages could be inhibited by the dysentery antigens.
Inhibition of Lysis of E. coli B by the
The viral inhibition tests were performed as outlined above. In each instance varying quantities of the inhibitor were incubated with the virus under investigation for 24 hours before plating. Platings were made simultaneously on Phase II Sk. sonnei and on E. coli B. The plates were incubated 12 hours at 37°C. before counting the plaques.
The results of these experiments are summarized in Table V where it can be seen that lysis of E. coli B by Ts, T4, and T~ was indeed inhibited by the Phase II antigen, and that lysis of the organism by T~, T2, T6, and T6 was in no way affected. Although data concerning the Phase I antigen are not included in I, serum before absorption with/~, coli B.
2, "
after
the table it should be stated that this substance caused no significant inhibition of any of the viruses. The significance of these results will be discussed later. Susceptible and Resistant Variants of T3.---It has been observed on occasions that certain stocks of Ts, "]?4, and T~ viruses, when stored at 5 ° C. over long periods of time, gradually lose their infectivity titers. In some instances these losses amount to as much as 3 log units. This change in titer is accompanied by a diminution in the capacity of the virus to be inhibited by the Phase II somatic antigen. Thus, a stock of T8 virus which had been kept for 8 months had dropped in titer from 1.2 X 10 ~° to 5 X l0 T particles per co. When the resistance pattern of the original virus was determined it was found to be fully susceptible to the action of the inhibitor. Whereas 103, 10 ~, and 101 micrograms of inhibitor inactivated in each instance 100, 99, and 65 per cent of the original virus, the aged virus showed 26, 7, and 0 per cent inactivation when tested with these same quantities of inhibitor. Similar observations were made on stocks of T4 and T~, though the decrease in susceptibility was not as striking.
In all instances the viruses could be restored to their original sensitivity by one or more passages on E. coli B in nutrient broth.
Since Ta appears to be the least susceptible to the action of the inhibitor, this virus was chosen for study in order to ascertain whether it might not contain particles resistant to the action of the agent. That this proved to be the case will be seen from the following.
To 1 cc. of the Ts stock containing 8 X 101° particles per cc. was added 1 cc. of a solution containing 5 rag. of the Phase II somatic antigen. A control tube was likewise prepared containing 1 cc. of virus diluted with an equal volume of the same buffer as that used in preparing the antigen solution. Both tubes were maintained at 37°C. and the virus concentrations determined in each at varying time intervals, using Phase II Sk. sonnd as the host cell. At the termination of the experiment the virus remaining in the tube containing the inhibitor was separated from the latter by centrifugation at 20,000 g for 1 hour. The virus was resuspended in 10 cc. of broth, again sedimented, and the washing repeated. The residual virus was now taken up in 2 cc. of broth and assayed (5 X 106). The resistance pattern of this virus, referred to in the accompanying table as TsRI, was then determined. The material was next divided into two equal portions. To one was added an equal volume of the inhibitor s6intion used above; the other, which served as a control, was diluted with an equal volume of buffer. Again the decrease in virus concentration was followed at the indicated time intervals, and the resistance pattern of the remaining virus (T,Rs) likewise determined.
The results of these experiments which are presented graphically in Fig. 2 and in Table VI reveal several salient facts. First, it should be pointed out that the rate of inactivation of the T3 virus is relatively slow. This is in contrast to the observation made on T4 which is rapidly inactivated by the Phase II antigen (2) . Second, it will be observed that by no means all of the virus was inactivated by the inhibitor. In a 72 hour period the titer of the virus had dropped from 8 X 101° to a constant value of 1 X l0 T. When the resistance pattern of this residual virus (T3R1) was determined (Table VI) approximately half of the viral particles were still found to be susceptible to the action of the inhibitor. The addition of new inhibitor to the sedimented and washed virus brought about a decrease in titer of about one-half log unit. This residual virus (T3R~) was now entirely resistant to the action of the inhibitor as can be seen in Table VI . Thus it appears that T3 consists of a population of at least two types of viral particles, those which combine with the specific inhibitor and are rendered incapable of infecting the host, and those which are unaffected even by high concentrations of the inhibitor and retain their ability to infect the Phase II microorganism. These two types of virus will be referred to as susceptible and resistant. They appear to coexist in normal stocks of T3 in the ratio of approximately 104:1, respectively. It wiU be shown later that in stocks of Ta still another variant exists which is incapable of infecting Phase II Sit. sonnei.
Is Resistance a Stable Characteristic?--If the property of resistance exhibited by the residual virus described above is transmissible to new generations of viral particles, it should be possible to demonstrate this in the virus of plaques arising from resistant particles.
0.1 cc. of a dilution of the resistant virus TsR~ containing 2 X l0 t particles per cc. was plated with Phase II Sk. sonnei. After 12 hours' incubation, ten of the plaques, which appeared on the plate and varying in size from 2 to 0.5 ram., were removed by means of a sterile glass eyedropper of appropriate diameter and having a flue sharpened edge. The plaques, together with the agar beneath them, were each transferred to 5 cc. of sterile broth at 0°C. After standing for 15 minutes the tubes were warmed to 37°C. for 7 minutes, again cooled to 0°C., and filtered in the cold to sterilize. The ten virus preparations were next assayed, then an aliquot diluted so as to contain 2 × 108 particles per ec. An equal volume of a sterile solution of the specific inhibitor containing 0.2 rag. per cc. was now added to each of the ten viruses. The tubes, together with the proper controls, were incubated at 37°C. for 24 hours and then plated using Phase II Sk. sonnei as the host. One hundred micrograms of inhibitor per ec: appears to be the optimal minimum amount of inhibitor necessary to give complete inhibition of all susceptible particles.
If the viruses obtained from the ten plaques had regained the property of susceptibility, the inhibition experiments performed at this one concentration of inhibitor should suffice to determine whether the newly generated viruses were resistant or susceptible. Despite the fact that the ten newly formed clones of viral particles had originated from single particles which were resistant (assuming, of course, that the particles themselves are not mixed aggregates), it can be seen from Table VII that the progeny had regained susceptibility. In each instance the viruses derived from the ten plaques were as susceptible to the action of the inhibitor as was the parent stock from which the resistant virus had been obtained. These experiments reveal that the property of resistance is not transmissible under the environmental conditions employed, and therefore it must be considered an unstable characteristic.
A second attempt was made to produce a resistant stock of virus by infecting colon bacilli actively growing in broth containing 1 rag. per cc. of the specific inhibitor, with a suspension of the resistant viral particles. Under these condi-tions it was thought that an environment unfavorable to the development of the susceptible particles but favorable to the development of resistant variants would be furnished.
3 cc. of nutrient broth containing 1 nag. of the Phase II antigen per cc. was inoculated with E. coli B. When growth had reached approximately 5 X l0 T bacilli per cc. the tube was infected with a total of 3 X los particles of the resistant virus T~R~ obtained as described above. After approximately 2 hours of aeration the tube had cleared. The contents were filtered and the virus then placed at 37°C. and assayed at the end of 24, 48, and 72 hours. It was found that the titer diminished progressively from approximately 3 X 10 ~° particles to S X l0 s particles in this time interval. A determination of the resistance pattern of the remaining virus showed that some 65 per cent of the viral particles were still susceptible to the action of the specific inhibitor. Repetition of the experiment, using the residual virus, yielded essentially the same results. The above experiment is further demonstration of the fact that infection of a bacterial population with the resistant variant of Ta yields progeny which is predominantly susceptible. The rapid drop in titer of the virus after the final burst is due to gradual inactivation of newly formed susceptible particles by the inhibitor. The fact that the rate of inactivation is relatively slow makes it possible to observe this phenomenon. That the titer of the virus drops only approximately 2 log units and leaves a population containing some 65 per cent of susceptible particles, is to be explained on the basis that the concentration of inhibitor is simply not sufficient to bring about complete inactivation of all susceptible particles. Two successive passages of the virus in the presence of inhibitor were made. Each time the virus was permitted to stand first for 72 hours at 37°C. before infecting new host cells. Each time the virus was passed, the newly formed virus showed on standing the same relative drop in titer as did the virus of the first passage. Although the environment was deemed favorable for the development of resistant virus, still it was not possible to obtain by this means a stock containing a preponderance of the resistant variant.
A Variant of T3 Specific for E. coli B.--If one assays a freshly prepared stock of T3 on Phase II Sh. sonnei and at the same time on E. coli B, it will be noticed that a slightly higher count is obtained on plates infected with the latter microorganism. If enough plates are counted to be of significance, it is found that there are approximately 5 to 10 per cent more plaques on those plates for which the colon bacillus served as the host cell. If one now makes a differential count of the residual T3 virus described above (i.e., of the virus which is no longer inhibitable by the Phase II antigen) it is found that the ratio of the number of plaques formed on Phase II to those appearing on E. coli B has increased from 1:1.12 to 1:40 (see Table VI ). The original T3 stock, in addition to containing a variant resistant to inhibition by the Phase II antigen, yet capable of infecting this cell, appears to contain still another variant. The latter is not inactivated by further addition of the Phase II antigen, and appears to be capable of infecting only E. coli B.
The so called resistant virus T3R2 was diluted so that on the average only one plaque was formed when 0.1 cc. of the dilution was plated with Phase II Sh. sonnei. When plated with E. coli B, this same dilution yielded an average of 41 plaques. Six of these plaques were now isolated and the virus recovered as described above. Each virus stock was assayed on E. coli B, then diluted to contain 1 X 103 particles per cc. 0.1 cc. of each dilution was now plated on Phase II Sh. sonnei and on E. coli B using four plates in each instance. After 12 hours' incubation the plaques were counted and the results tabulated (Table VIII) . Since the resistant virus had been so diluted that the probability of selecting a plaque arising from a viral partide infective only for E. coli B, and not for Phase II Sh. sonnei, was 40:1, the chance was sl/ght that one of the six plaques selected would be reactive with both organisms.
The results presented in Table VIII indicate quite clearly that transmission of the property of specificity for E. coli B, under the environmental conditions selected, cannot be achieved. The clone of viral particles in the six plaques under investigation probably all arose from individual viral particles capable of infecting only E. coli B. Yet the new viral population in each instance consisted of particles capable of infecting both those cells and they occurred essentially in the same ratio as that in the virus stock from which the so called resistant virus had originally been prepared. In this respect the second variant shows unstable characteristics similar to those noted above.
DISCUSSION
When a susceptible bacteriophage is brought into contact with a sufficiently high concentration of a specific inhibitor, the two substances appear to interact and the virus is rendered incapable of infecting the host from which the inhibitor was derived. The nature of the chemical union between inhibitor and phage is not understood, nor is it yet known whether the virus itself is irreparably altered. Furthermore, it has not yet been ascertained whether infectious virus can be released from the inactive complex. Although the mechanism of its action is obscure, the fact remains that the somatic antigen of Phase II Sh. sonnei can specifically inactivate in vitro three of the T viruses, T3, T4, and TT. It has been suggested therefore that this substance, distributed on the surface of the dysentery bacillus, serves as the receptor for the phages in question at the instant of inception of the infectious process. From immunological evidence presented in this communication it has been shown that an antigen similar to that of Phase II Sh. sonnei is present on the cell surface of E. coli B, and it is suggested that this antigen serves in a similar capacity when the colon bacillus undergoes infection with T3, T4, or TT."
That the two microorganisms possess a similar surface antigen is substantiated by the fact that the colon bacillus agglutinates in an antiserum to the chemically purified dysentery antigen, and by the fact that the latter is precipitated by an antiserum to the colon bacillus. These antigens are not identical, however, for some, but not all, of the antibodies are removed from Phase II antigen immune serum by absorption with E. coli B. Since the two antigens show immunological crossing they must likewise be related chemically. It is reasonable to think, therefore, that these two substances can function similarly as receptors for the same viruses. The isolation of the new antigen from E. coli B has not been undertaken. It cannot be said therefore whether it is a single chemical entity, or a part of a more complex molecule which has affinity for others of the T series of viruses.
There are many examples among antigen-antibody reactions for which it has been shown that part but not all of the antibody protein combines with an heterologous antigen. One example was reported from this laboratory many years ago (12) . It was shown that the native capsular polysaccharide of Type I pneumococcus possesses a labile acetyl group. When the latter was removed, the resulting deacetylated polysaccharide was still capable of reacting with Type I antibody. When sera were absorbed with the deacetylated polysaccha-ride, a residue of antibody remained which failed to react with the chemically altered carbohydrate but was still reactive with the native polysacchaxide. It is conceivable that the isolated antigen of Phase II Sh. sonnei has suffered alteration during its chemical purification. As finally isolated it may no longer represent an exact replica of the bacterial antigen as it occurs in its native state and hence cannot carry to completion the inactivation of all the T3 viral particles in a given population.
Assuming this to be so, one might anticipate finding in a virus-inhibitor mixture only residual particles capable of infecting both host cells, Phase II Sh. sonnei and E. coli B. This is not the case, however, for it has been seen that the partially inhibited residual virus TsR1 is but slightly affected by fresh bacterial antigen. The decrease in titer which takes place is slight and equals the residual susceptible viral particles. The virus which remains, T~R2, is no longer affected by the specific inhibitor. Moreover, it contains a variant having a specificity different from that of the majority of the original viral particles.
Thus it has been shown that stocks of T~, after treatment with the inhibitor, contain at least two variants, neither of which is inhibited by further treatment with the Phase II antigen. One of these combines with and infects both the Phase II dysentery bacillus and E. coli B; the other infects only the latter microorganism. This fact suggests the hypothesis that both microorganisms possess still other receptors through which these variants, and indeed other viruses, as well, can combine and bring about the infectious process. The nature of these receptors is not yet known.
Those who have studied the inhibition of phages by extracts of microorganisms (13) and by specific antisera (14) have come to the conclusion that viral populations are probably not homogeneous but may contain a small proportion of particles which are relatively resistant to these agents. Several investigators have demonstrated that the property of resistance cannot be transmitted to new generations of viral particles. In certain respects the action of the Phase II antigen of Sh. sonnei on the T, virus is comparable to that of a specific antiserum. When virus and inhibitor are mixed the majority of particles are rendered incapable of infecting the host cell but a small portion remains which is resistant to the inhibitor. In the case of the resistant virus T3R1 and the residual virus T3R2, which exhibits specificity only for g. coli B, it cannot be said whether these variants arise as a result of the action of the specific inhibitor on normal virus particles, or whether they are naturally occurring phenotypic variants. One fact seems to be clear, however, and that is neither of these properties appears to be transmissible to new generations of virus particles.
During the course of this investigation the author has discussed it often with Dr. Frank L. Horsfall, Jr., and with Dr. Ruth Sager. He wishes to express his appreciation for their interest and for their many stimulating suggestions.
SUMM.ARY
By serological means it has been shown that E. coli B contains an antigen closely related to the protein-lipocarbohydrate complex of Phase II Sh. sonnei. Lysis of E. coli B by three of the T viruses, T3, T4, and Tv, can be inhibited by the Phase II dysentery antigen. It has been suggested that the receptor of E. coli B with which these viruses combine is this newly described antigenic component. Two variants of the virus T3 have also been described, in stocks which have been treated with the Phase II antigen. One of these variants infects both Phase II Sh. sonnei and E. coli B, and the other infects only the latter microorganism; neither of the two variants is inhibited by concentrations of the Phase II antigen of 1 rag. per cc. The distinctive properties of the variants are not hereditary. 
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and mechanical assistance in the execution of this task is essential The conventional Quebec counter is helpful, and the addition of an electrically operated counting device described by Varney (15) is a decided improvement. Unfortunately this equipment is no longer available commercially nor to our knowledge is any other mechanical device for counting bacterial colonies. A simple apparatus has therefore been devised which has been of great assistance in counting accurately and rapidly bacteriophage plaques. A 4 X 5 inch DeJur professional model photographic enlarger, having the light and STUDIES ON BACTERIOPHAGE. II condenser housing separated from the bellows, was fitted with a sliding bakelite adapter built to carry two Petri dishes (Fig. 3) . A 150 watt bulb served as the light source and an F 4. pencil was inserted was wired in series with the counter and was operated from the 110 volt A.C. circuit (Fig. 4) . When the tip of the pencil is touched to the paper, contact is made within the switch and the impulse is registered in the counter. The Petri dish without its lid, is inserted face downward in the adapter. The image of the dish, magnified two and one-half fold, is projected on a sheet of paper placed on the enlarger easel board. The images of the plaques can be counted either by touching individually, or by streaking five at once. A plate with 100 plaques can be counted in less than a minute.
If the Petri dish holder is constructed to hold the dish without its lid and with the agar half facing the lens, an image is had which extends to the very edge of the dish. Thus it is possible to see all the plaques on the agar surface except those which, because of the pouring technique, have crept to the perpendicular edge. If the pouring is carefully done, there will be few plaques in this position, and any error introduced by plaques which are not visible is small. This can of course be corrected by counting the latter in the conventional manner. This equipment can also be used to count bacterial colonies, to examine the morphology of phage plaques and bacterial colonies as well. Permanent negative records can be made by projecting the image on sensitized paper and developing the latter.
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